Patents Assigned to VONSUN PHARMATECH CO., LTD.
  • TRIPLE AGONIST FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR, GLUCAGON RECEPTOR, AND GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR
    Publication number: 20230067960
    Abstract: Provided is a triple agonist for the glucagon-like peptide-1 receptor (GLP1-R), glucagon receptor (GCGR), and gastric inhibitory polypeptide receptor (GIPR), the triple agonist being based on the amino acid sequence of natural exendin-4 with at least one site having an amino acid substitution, mutation, or chemical modification. The triple agonist of the present invention can be used for the prevention or treatment of metabolic syndrome.
    Type: Application
    Filed: February 7, 2021
    Publication date: March 2, 2023
    Applicant: VONSUN PHARMATECH CO., LTD.
    Inventors: Zhongshuai XIN, Yifei LI, Liangzhu WEN, Yuanguang ZHONG, Huimei CHEN, Mingyi ZHANG, Mei ZHAO